CRL Charles River Laboratories International, Inc.
Healthcare$160.30+0.91%ClosedMarket Cap: $7.72B
As of 2026-05-25
Insider Statistics (Q2 2026)
Acquisitions
17
Dispositions
1
Buy/Sell Ratio
17.00
Net Shares
+39,744
Shares Acquired
43,708
Shares Disposed
3,964
Total Bought ($)
$0.00
Total Sold ($)
$0.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Thu May 14 | Andrews Nancy C | director | Sell | 3,964 | $0.00 | 3,964 |
| Tue May 12 | Thompson Craig B. | director | Sell | 1,438 | $177.62 | 3,851 |
| Tue May 12 | Graves Paul W | director | Sell | 1,438 | $177.62 | 2,384 |
| Tue May 12 | Barg Steven | director | Sell | 1,438 | $177.62 | 2,865 |
| Mon May 11 | WILSON VIRGINIA M | director | Sell | 1,438 | $177.62 | 6,349 |
| Mon May 11 | MACKAY MARTIN | director | Sell | 1,438 | $177.62 | 15,730 |
| Mon May 11 | MACKAY MARTIN | director | Sell | 1,407 | $177.62 | 17,137 |
| Mon May 11 | Llado George Sr. | director | Sell | 1,438 | $177.62 | 6,252 |
| Mon May 11 | Llado George Sr. | director | Sell | 450 | $177.62 | 6,702 |
| Mon May 11 | Kemps-Polanco Reshema | director | Sell | 1,438 | $177.62 | 4,028 |
| Mon May 11 | Kemps-Polanco Reshema | director | Sell | 535 | $177.62 | 4,563 |
| Mon May 11 | Enyedy Mark J | director | Sell | 1,438 | $177.62 | 2,384 |
| Mon May 11 | Ceesay Abraham | director | Sell | 1,438 | $177.62 | 2,384 |
| Mon May 11 | Andrews Nancy C | director | Sell | 1,438 | $177.62 | 5,402 |
| Mon May 04 | Coleman Glenn | officer: EVP & Chief Financial Officer | Sell | 21,112 | $165.78 | 21,112 |